Duchenne muscular dystrophy: preliminary experience with sacubitril-valsartan in patients with asymptomatic left ventricular dysfunction.
CONCLUSIONS: Our preliminary data suggest that, in DMD patients with reduced LV ejection fraction, S/V is safe and may improve LV function.
PMID: 32965001 [PubMed - as supplied by publisher]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Brain | Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | Diovan | Drugs & Pharmacology | Genetics | Heart | Heart Failure | Muscular Dystrophy | Neurology | Reflex Sympathetic Dystrophy | Study